SEC Form 4 · accession 0001645627-18-000024
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 1, 2018
Accepted (ET)
May 10, 2018 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2018 | P | 1,000 | $0.0323 | A | 24,997,989 | D | |
| Common Stock | May 1, 2018 | P | 1,000 | $0.0327 | A | 24,998,989 | D | |
| Common Stock | May 1, 2018 | P | 2,000 | $0.032 | A | 25,000,989 | D | |
| Common Stock | May 1, 2018 | P | 100 | $0.0322 | A | 25,001,089 | D | |
| Common Stock | May 1, 2018 | P | 1,000 | $0.0328 | A | 25,002,089 | D | |
| Common Stock | May 1, 2018 | P | 100 | $0.0336 | A | 25,002,189 | D | |
| Common Stock | May 1, 2018 | P | 2,000 | $0.0336 | A | 25,004,189 | D | |
| Common Stock | May 1, 2018 | P | 1,000 | $0.0337 | A | 25,005,189 | D | |
| Common Stock | May 1, 2018 | P | 100 | $0.0332 | A | 25,005,289 | D | |
| Common Stock | May 1, 2018 | P | 1,000 | $0.0336 | A | 25,006,289 | D | |
| Common Stock | May 1, 2018 | P | 1,000 | $0.0336 | A | 25,007,289 | D | |
| Common Stock | May 1, 2018 | P | 1,000 | $0.0307 | A | 25,008,289 | D | |
| Common Stock | May 2, 2018 | P | 2,000 | $0.0328 | A | 25,010,289 | D | |
| Common Stock | May 2, 2018 | P | 1,000 | $0.0318 | A | 25,011,289 | D | |
| Common Stock | May 3, 2018 | P | 1,000 | $0.0317 | A | 25,012,289 | D | |
| Common Stock | May 3, 2018 | P | 1,000 | $0.033 | A | 25,013,289 | D | |
| Common Stock | May 4, 2018 | P | 1,000 | $0.0348 | A | 25,014,289 | D | |
| Common Stock | May 4, 2018 | P | 1,000 | $0.0345 | A | 25,015,289 | D |
Table II — derivative securities
No Table II lines on this filing.